The aim of this study was to further elucidate the association between BCRP expression and 5-FU resistance in clinical breast cancer tissue specimens and optimize breast cancer clinical chemotherapy schemes in BCRP-positive specimens. The gene discussed is ABCG2; the disease is breast cancer.